Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Efficacy and safety of a biodegradable polymer Cobalt‐Chromium sirolimus‐eluting stent (EXCEL2) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials

Geng Wang MD, Heyang Wang MD, Bo Xu MBBS, Yuejin Yang MD, Zhiming Yang MD, Hui Li MD, Zheng Zhang MD, Haichang Wang MD, Lixia Yang MD, Yaling Han MD, FACC

Background: The safety and efficacy of the second‐generation biodegradable polymer Cobalt‐Chromium sirolimus‐eluting stent (EXCEL2) in daily clinical practice remains unknown. Additionally, to meet the China Food and Drug Administration requirements, we conducted an objective performance criterion study from the CREDIT II and CREDIT III trials.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Comparison of two biodegradable‐polymer‐based sirolimus‐eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial

Changdong Guan MSc, Bo Xu MBBS, Shubin Qiao MD, Lei Qin MD, Yi Li MD, Zhanquan Li MD, Yong Guo MD, Zhongwei Sun MSc, Lei Song MD, Runlin Gao MD, on behalf of the PANDA III Investigators

Background: Implantation of early‐generation metallic drug‐eluting stents (DES) in patients with acute myocardial infarction (AMI) is associated with poor vessel wall healing. Use of biodegradable polymer (BP) DES might improve safety outcomes; however, the impact of varying drug elution and polymer absorption kinetics of BP‐DES on clinical outcomes in the AMI population is unknown.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?

Jose F. Condado MD, MS, Moosa N. Haider MD, MBA, Stamatios Lerakis MD, Patricia Keegan NP, Hope Caughron BA, Vinod H. Thourani MD, Chandan Devireddy MD, Bradley Leshnower MD, Kreton Mavromatis MD, Eric L. Sarin MD, James Stewart MD, Robert Guyton MD, Jessica Forcillo MD, Ateet Patel MD, Amy Simone PA, Peter C. Block MD, Vasilis Babaliaros MD

Objectives: To compare outcomes after minimalist and standard transfemoral transcatheter aortic valve replacement (TF‐TAVR) in patients with severe chronic obstructive pulmonary disease (COPD).

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Left atrial appendage closure: A single center experience and comparison of two contemporary devices

Filippo Figini, Patrizio Mazzone, Damiano Regazzoli, Giulia Porata, Neil Ruparelia, Francesco Giannini, Stefano Stella, Francesco Ancona, Eustachio Agricola, Nicoleta Sora, Alessandra Marzi, Andrea Aurelio, Nicola Trevisi, Paolo Della Bella, Antonio Colombo, Matteo Montorfano

Objectives: To compare indications and clinical outcomes of two contemporary left atrial appendage (LAA) percutaneous closure systems in a “real‐world” population.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Closure of very large PDA with pulmonary hypertension: Initial clinical case‐series with the new Occlutech® PDA occluder

Anja Lehner MD, Sarah Ulrich MD, Christoph M. Happel MD, PhD, Marcus Fischer MD, Marinos Kantzis MD, Ingram Schulze‐Neick MD, PhD, Nikolaus A. Haas MD, PhD

Objective. We report our recent experience with the new Occlutech® PDA Occluder, which seems suitable especially for closure of large patent ductus arteriosus (PDA) sizes with elevated pulmonary artery pressure (PAH).

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Stenting of the ductus arteriosus in infants with functionally univentricular heart disease and ductal‐dependent pulmonary blood flow: A single‐center experience

Ahmet Celebi MD, Ilker Kemal Yucel MD, Mustafa Orhan Bulut MD, Mehmet Kucuk MD, Sevket Balli MD

Objective: To determine the short‐ and medium‐term outcomes of ductal stenting (DS) in patients with functionally univentricular hearts (FUHs) and ductal‐dependent pulmonary blood flow.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Techniques for transcatheter retrieval of the occlutech ASD device United Kingdom–European multicenter report

Suhair O Shebani MBBCh, MSc, FRCPCH, Rizwan Rehman MBChB MRCPCH, Demetris Taliotis MBCHB, MRCPCH, Alan Magee MBBCh, MD, FRCP, Nicholas J Hayes BSc, MBChB, MRCPCH , Osman Baspinar MD, Zunzunegui Martínez JD, MD, Nikolaus Haas MD, PhD, FRACP, Christopher Duke MBChB, FRCP

Aims: To gather current experience in Occlutech ASD device retrieval, to determine whether snaring is an effective technique and to highlight alternative retrieval techniques.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Intracoronary optical coherence tomography: Clinical and research applications and intravascular imaging software overview

Erhan Tenekecioglu MD, Felipe N. Albuquerque MD, Yohei Sotomi MD, Yaping Zeng MD, PhD, Pannipa Suwannasom MD, Hiroki Tateishi MD, PhD, Rafael Cavalcante MD, PhD, Yuki Ishibashi MD, Shimpei Nakatani MD, Mohammad Abdelghani MD, Jouke Dijkstra PhD, Christos Bourantas MD, PhD, Carlos Collet MD, Antonios Karanasos MD, Maria Radu MD, PhD, Ancong Wang PhD, Takashi Muramatsu MD, PhD, Ulf Landmesser MD, PhD, Takayuki Okamura MD, PhD, Evelyn Regar MD, PhD, Lorenz Räber MD, PhD, Giulio Guagliumi MD, Robert T. Pyo MD, Yoshinobu Onuma MD, PhD, Patrick W. Serruys MD, PhD

By providing valuable information about the coronary artery wall and lumen, intravascular imaging may aid in optimizing interventional procedure results and thereby could improve clinical outcomes following percutaneous coronary intervention (PCI). Intravascular optical coherence tomography (OCT) is a light‐based technology with a tissue penetration of approximately 1 to 3 mm and provides near histological resolution. It has emerged as a technological breakthrough in intravascular imaging with multiple clinical and research applications. OCT provides detailed visualization of the vessel following PCI and provides accurate assessment of post‐procedural stent performance including detection of edge dissection, stent struts apposition, tissue prolapse, and healing parameters. Additionally, it can provide accurate characterization of plaque morphology and provides key information to optimize post‐procedural outcomes. This manuscript aims to review the current clinical and research applications of intracoronary OCT and summarize the analytic OCT imaging software packages currently available.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS.First reported use of drug‐coated balloon for bioresorbable in‐scaffold restenosis

Roberto Adriano Latini MD, Dario Buccheri MD, Bernardo Cortese MD

This is the first documented case of a drug‐coated balloon strategy for the treatment of bioresorbable in‐scaffold restenosis caused by diffuse neointimal proliferation. This case can provide an alternative treatment option in this setting, avoiding potential problems related to further bulky metallic stents in a patient where a different strategy was initially planned.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Fluoroscopy pulse rate reduction during diagnostic and therapeutic imaging in the cardiac catheterization laboratory: An evaluation of radiation dose, procedure complications and outcomes

James W. Hansen DO, Andrew Foy MD, Torrey Schmidt DO, Mehrdad Ghahramani MD, Charles E. Chambers MD

Objectives: To evaluate radiation reduction by reducing fluoroscopy pulse rate in diagnostic cardiac catheterizations and percutaneous coronary interventions (PCI) as well as outcomes at 30 days and six months.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Compared to femoral venous access, upper extremity right heart catheterization reduces time to ambulation: A single center experience

Bernadette Speiser MSN, Katrina Pearson BSN, Hui Xie PhD, Adhir R. Shroff MD, MPH, FACC, FSCAI, Mladen I. Vidovich

Background: Transradial coronary angiography has been associated with shorter times to ambulation. We hypothesized that RHC from the upper extremity would be similarly associated with shorter ambulation times when compared to traditional femoral access.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Comparison of the ipsi‐lateral versus contra‐lateral retrograde approach of percutaneous coronary interventions in chronic total occlusions

Kambis Mashayekhi MD, Michael Behnes MD, Zivile Valuckiene MD, Leszek Bryniarski MD, Ibrahim Akin MD, Hans Neuser MD, Franz‐Josef Neumann MD, PhD, Nicolaus Reifart MD, PhD

Background: Retrograde recanalization of coronary chronic total occlusions (CTO) via contralateral (CL) collateral connections (CCs) is successful in 60–70% of patients in whom conventional antegrade approach fails or is unpromising. This study describes our experience with retrograde CTO‐PCI via ipsi‐lateral (IL) CCs in patients with unfavorable CL CCs.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions

Edward Koifman MD Michael A. Gaglia Jr. MD Ricardo O. Escarcega MD Nelson L. Bernardo MD Robert A. Lager MD Robert A. Gallino MD Itsik Ben‐Dor MD Augusto D. Pichard MD Nevin C. Baker DO Michael J. Lipinski MD, PhD Sarkis Kiramijyan MD Smita I. Negi MD Rebecca Torguson MPH Jiaxiang Gai MSPH William O. Suddath MD Lowell F. Satler MD Ron Waksman MD

Objective: Comparison of transradial versus transfemoral access for complex percutaneous coronary intervention (PCI) with regard to both complications and long‐term outcomes.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Sex‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study

Jaya Chandrasekhar MBBS, Usman Baber MD, MS, Samantha Sartori PhD, Michela Faggioni MD, Melissa Aquino MS, Annapoorna Kini MBBS, William Weintraub MD, Sunil Rao MD, Samir Kapadia MD, Sandra Weiss MD, Craig Strauss MD, Catalin Toma MD, Brent Muhlestein MD, Anthony DeFranco MD, Mark Effron MD, Stuart Keller BPharm, Brian Baker PharmD, Stuart Pocock PhD, Timothy Henry MD, Roxana Mehran MD

Background: Young women undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) experience greater adverse events than men, potentially due to under‐treatment. We sought to compare the 1‐year outcomes by sex in patients ≤55 years of age from a contemporary PCI cohort.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Patient and lesion‐specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery

Ehrin J. Armstrong MD, MSc, Laura Graham MPH, Stephen W. Waldo MD, Javier A. Valle MD, MSc, Thomas M. Maddox MD, MSc, Mary T. Hawn MD

Objectives: To identify predictors of major adverse cardiovascular outcomes (MACE) among patients with prior percutaneous coronary intervention (PCI) who require noncardiac surgery.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.